Position in ANIP
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$589,807
+$49,200 QoQ
Shares Held
7,125
+1.4% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#166
of 306 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $10,837,032 across 10 Drug Manufacturers - Specialty & Generic names. ANIP ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
|
317,960 | $3,179,600 | |
| 2 | ZTS |
Zoetis Inc.
|
29,756 | $2,138,266 | |
| 3 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
112,447 | $2,019,548 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
54,068 | $783,445 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,405 | $761,271 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
This page
|
7,125 | $589,807 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
14,552 | $526,782 | |
| 8 | PAHC |
Phibro Animal Health Corp
|
10,131 | $318,113 |
All Filings in ANIP
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $589,807 | 7,125 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $540,607 | 7,030 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||